A unique vaccine for birth control and treatment of advanced stage cancers secreting ectopically human chorionic gonadotropin-Reference-Cited by-同舟云学术

A unique vaccine for birth control and treatment of advanced stage cancers secreting ectopically human chorionic gonadotropin

Published:2021-12-16 Issue: Volume: Page:
ISSN:2768-6655
Container-title:Exploration of Immunology
language:en
Short-container-title:Explor Immunol

Author:

Talwar Gursaran P.¹,Gupta Jagdish C.¹,Purswani Shilpi²,Vyas Hemant K.³,Nand Kripa N.¹,Pal Priyanka¹,Ella Krishna M.⁴

Affiliation:

1. Talwar Research Foundation, New Delhi 110068, India

2. Talwar Research Foundation, New Delhi 110068, India; Qiagen Sciences Inc., Germantown, MD 20874, USA

3. Talwar Research Foundation, New Delhi 110068, India; uniQure USA, Lexington, MA 02421, USA

4. Bharat Biotech International Ltd, Hyderabad, Telangana 500078, India

Abstract

This article is a tribute and homage to Gerard Chaouat who invited me to contribute this article. My years in France have remained very memorable to me. Reviewed briefly is the vaccine that was made against human chorionic gonadotropin (hCG) to prevent unwanted pregnancy in sexually active women. It has now been developed as a genetically engineered recombinant vaccine and passed onto industry for its production under good manufacturing practices (GMP) conditions for confirmatory trials. The trials have received the approval of the Drugs Controller General of India. The trials have started but have been interrupted by the coronavirus disease 2019 (COVID-19) pandemic. This vaccine is likely to have another highly beneficial application in the treatment of cancers expressing ectopically hCG.

Funder

Indian Council of Medical Research

Department of Biotechnology, Ministry of Science and Technology, India

Publisher

Open Exploration Publishing

Reference23 articles.

1. Talwar GP, Singh O, Pal R, Chatterjee N, Sahai P, Dhall K, et al. A vaccine that prevents pregnancy in women. Proc Natl Acad Sci U S A. 1994;91:8532-6.

2. Talwar GP, Singh O, Rao LV. An improved immunogen for anti-human chorionic gonadotropin vaccine eliciting antibodies reactive with a conformation native to the hormone without cross-reaction with human follicle stimulating hormone and human thyroid stimulating hormone. J Reprod Immunol. 1988;14:203-12.

3. Singh M, Das SK, Suri S, Singh O, Talwar GP. Regain of fertility and normality of progeny born during below protective threshold antibody titers in women immunized with the HSD-hCG vaccine. Am J Reprod Immunol. 1998;39:395-8.

4. Kaliyaperumal A, Chauhan VS, Talwar GP, Raghupathy R. Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate. Eur J Immunol. 1995;25:3375-80.

5. Purswani S, Talwar GP. Development of a highly immunogenic recombinant candidate vaccine against human chorionic gonadotropin. Vaccine. 2011;29:2341-8.